Luo Yongqing

Luo Yongqing, listed as chief executive, has filed trades across 2 companies (mainly through HKEX), most often in Everest Medicines Ltd. and Brii Biosciences Ltd. - B. We count 18 filings; the first trade dates from 13 July 2021 and the latest from 30 June 2026.

Both buying and selling appear: 7 purchases worth €658k, against 2 sales. The amount is not disclosed for 8 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

Most recently, on 19 August 2026, the filings show a transaction in Everest Medicines Ltd. The clock since the last published purchase (16 December 2025) now reads 312 days. Filings reach the HKEX feed a median of 10 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.